Ratings PT Gudang Garam Tbk Deutsche Boerse AG

Equities

GGG

ID1000068604

Market Closed - Deutsche Boerse AG Other stock markets 02:03:11 2024-04-29 am EDT			5-day change	1st Jan Change
1 ^EUR	-10.71%		-10.71%	-9.09%

Mar. 28	PT Gudang Garam Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	PT Gudang Garam Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Strengths

The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company shows low valuation levels, with an enterprise value at 321.23 times its sales.
The company appears to be poorly valued given its net asset value.
This company will be of major interest to investors in search of a high dividend stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company's earnings growth outlook lacks momentum and is a weakness.
As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the last few months, analysts have been revising downwards their earnings forecast.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Tobacco

	1st Jan change	Capi.	ESG Refinitiv
PT GUDANG GARAM TBK	-9.09%	2.27B	-
ALTRIA GROUP, INC.	+8.63%	74.51B	B-
ITC LIMITED	-5.17%	65.87B	B
JAPAN TOBACCO, INC.	+14.60%	47.11B	A-
KT&G CORPORATION	+3.34%	7.29B	A-
PT HANJAYA MANDALA SAMPOERNA TBK	-5.59%	5.99B	A-
RLX TECHNOLOGY INC.	-2.00%	2.43B	C-
BRITISH AMERICAN TOBACCO BANGLADESH COMPANY LIMITED	-27.82%	1.79B	-
SCANDINAVIAN TOBACCO GROUP A/S	-3.32%	1.36B	B
EASTERN COMPANY S.A.E	-15.49%	1.12B	D+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes